SIVEXTRO® (POWDER)

Drug Information Related Patent

Hold Company

MERCK SHARP DOHME

Learn More

Dosage and Administration

POWDER;INTRAVENOUS

Specification

200MG/VIAL

Indication

SIVEXTRO® is an oxazolidane antimicrobial agent indicated for the treatment of acute bacterial skin and skin structure infections caused by sensitive isolates of Gram-positive organisms in adults and pediatric patients 12 years and older.

Use

Instructions for Use

API

TEDIZOLID PHOSPHATE

API Structure

We Supply

TEDIZOLID PHOSPHATE

Note:

In-house Standard
Facility GMP
CDE

null

Note:

null

Note:

null

Drug Patent

Patent No	Expiration Date
10065947	2030/2/3
10442829	2030/2/3
7816379	2028/6/20
8420676	2028/2/23
8426389	2030/12/31
9624250	2030/2/3
9988406	2030/2/3

API Patent

Patent No	Expiration Date
10065947	2030/2/3
10442829	2030/2/3
7816379	2028/6/20
8420676	2028/2/23
8426389	2030/12/31
9624250	2030/2/3
9988406	2030/2/3

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Tel:
E-mail:
Address:
WhatsAPP

Member of

CERTIFICATION